Charles Schwab’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.6M Sell
1,617,617
-16,260
-1% -$247K ﹤0.01% 1554
2025
Q1
$27.3M Sell
1,633,877
-22,443
-1% -$375K 0.01% 1450
2024
Q4
$31.2M Sell
1,656,320
-1,399,250
-46% -$26.4M 0.01% 1433
2024
Q3
$57.4M Buy
3,055,570
+45,359
+2% +$852K 0.01% 1031
2024
Q2
$56.9M Buy
3,010,211
+122,711
+4% +$2.32M 0.01% 968
2024
Q1
$46.9M Buy
2,887,500
+164,546
+6% +$2.67M 0.01% 1085
2023
Q4
$34.5M Buy
2,722,954
+148,307
+6% +$1.88M 0.01% 1243
2023
Q3
$35.1M Buy
2,574,647
+81,248
+3% +$1.11M 0.01% 1143
2023
Q2
$42.8M Buy
2,493,399
+16,506
+0.7% +$283K 0.01% 958
2023
Q1
$34.5M Buy
2,476,893
+17,908
+0.7% +$249K 0.01% 1083
2022
Q4
$32.9M Buy
2,458,985
+118,569
+5% +$1.59M 0.01% 1094
2022
Q3
$27.9M Buy
2,340,416
+110,369
+5% +$1.31M 0.01% 1147
2022
Q2
$28.4M Buy
2,230,047
+123,897
+6% +$1.58M 0.01% 1135
2022
Q1
$27.2M Sell
2,106,150
-15,735
-0.7% -$203K 0.01% 1304
2021
Q4
$33.6M Buy
2,121,885
+31,561
+2% +$500K 0.01% 1186
2021
Q3
$40.7M Buy
2,090,324
+35,212
+2% +$686K 0.01% 1019
2021
Q2
$46.8M Buy
2,055,112
+93,947
+5% +$2.14M 0.02% 920
2021
Q1
$36M Buy
1,961,165
+49,030
+3% +$901K 0.01% 1053
2020
Q4
$28.5M Buy
1,912,135
+7,608
+0.4% +$113K 0.01% 1144
2020
Q3
$21.4M Sell
1,904,527
-96,352
-5% -$1.08M 0.01% 1154
2020
Q2
$15.9M Sell
2,000,879
-158,802
-7% -$1.26M 0.01% 1339
2020
Q1
$17.5M Buy
2,159,681
+22,501
+1% +$182K 0.01% 1101
2019
Q4
$26.9M Sell
2,137,180
-5,344
-0.2% -$67.2K 0.01% 1009
2019
Q3
$19.1M Buy
2,142,524
+65,267
+3% +$583K 0.01% 1169
2019
Q2
$17.8M Buy
2,077,257
+7,843
+0.4% +$67.1K 0.01% 1224
2019
Q1
$15.7M Buy
2,069,414
+124,495
+6% +$945K 0.01% 1268
2018
Q4
$16.1M Sell
1,944,919
-198,533
-9% -$1.64M 0.01% 1133
2018
Q3
$21.3M Buy
2,143,452
+184,800
+9% +$1.83M 0.01% 1099
2018
Q2
$19.2M Buy
1,958,652
+120,809
+7% +$1.18M 0.01% 1116
2018
Q1
$17.1M Sell
1,837,843
-12,119
-0.7% -$113K 0.01% 1111
2017
Q4
$17.6M Buy
1,849,962
+3,650
+0.2% +$34.7K 0.01% 1076
2017
Q3
$19.1M Buy
1,846,312
+51,590
+3% +$534K 0.02% 959
2017
Q2
$14.8M Buy
1,794,722
+159,317
+10% +$1.32M 0.01% 1073
2017
Q1
$11.8M Buy
1,635,405
+143,402
+10% +$1.03M 0.01% 1202
2016
Q4
$10.7M Buy
1,492,003
+192,887
+15% +$1.38M 0.01% 1206
2016
Q3
$9.45M Buy
1,299,116
+148,092
+13% +$1.08M 0.01% 1210
2016
Q2
$6.74M Buy
1,151,024
+93,381
+9% +$547K 0.01% 1352
2016
Q1
$6.73M Buy
1,057,643
+88,972
+9% +$566K 0.01% 1318
2015
Q4
$6.22M Buy
968,671
+63,917
+7% +$410K 0.01% 1367
2015
Q3
$5.26M Buy
904,754
+64,634
+8% +$376K 0.01% 1431
2015
Q2
$7.33M Buy
840,120
+137,643
+20% +$1.2M 0.01% 1275
2015
Q1
$5.61M Buy
702,477
+97,286
+16% +$777K 0.01% 1426
2014
Q4
$4.7M Buy
605,191
+34,978
+6% +$271K 0.01% 1496
2014
Q3
$3.7M Buy
570,213
+79,008
+16% +$512K 0.01% 1602
2014
Q2
$4.13M Buy
491,205
+95,381
+24% +$802K 0.01% 1552
2014
Q1
$2.66M Buy
395,824
+63,034
+19% +$423K ﹤0.01% 1792
2013
Q4
$2.08M Buy
332,790
+20,648
+7% +$129K ﹤0.01% 1897
2013
Q3
$1.38M Buy
312,142
+51,708
+20% +$229K ﹤0.01% 2048
2013
Q2
$1.15M Buy
+260,434
New +$1.15M ﹤0.01% 2075